Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,631 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.
Guenther A, Krauss E, Tello S, Wagner J, Paul B, Kuhn S, Maurer O, Heinemann S, Costabel U, Barbero MAN, Müller V, Bonniaud P, Vancheri C, Wells A, Vasakova M, Pesci A, Sofia M, Klepetko W, Seeger W, Drakopanagiotakis F, Crestani B. Guenther A, et al. Among authors: muller v. Respir Res. 2018 Jul 28;19(1):141. doi: 10.1186/s12931-018-0845-5. Respir Res. 2018. PMID: 30055613 Free PMC article.
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, Pittrow D, Swigris J, Antoniou K, Baughman RP, Castelino FV, Christmann RB, Christopher-Stine L, Collard HR, Cottin V, Danoff S, Highland KB, Hummers L, Shah AA, Kim DS, Lynch DA, Miller FW, Proudman SM, Richeldi L, Ryu JH, Sandorfi N, Sarver C, Wells AU, Strand V, Matteson EL, Brown KK, Seibold JR; CTD-ILD Special Interest Group. Saketkoo LA, et al. Thorax. 2014 May;69(5):428-36. doi: 10.1136/thoraxjnl-2013-204202. Epub 2013 Dec 24. Thorax. 2014. PMID: 24368713 Free PMC article.
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Maher TM, Ford P, Brown KK, Costabel U, Cottin V, Danoff SK, Groenveld I, Helmer E, Jenkins RG, Milner J, Molenberghs G, Penninckx B, Randall MJ, Van Den Blink B, Fieuw A, Vandenrijn C, Rocak S, Seghers I, Shao L, Taneja A, Jentsch G, Watkins TR, Wuyts WA, Kreuter M, Verbruggen N, Prasad N, Wijsenbeek MS; ISABELA 1 and 2 Investigators. Maher TM, et al. JAMA. 2023 May 9;329(18):1567-1578. doi: 10.1001/jama.2023.5355. JAMA. 2023. PMID: 37159034 Free PMC article.
Short- and long-term clinical outcomes of nintedanib therapy in IPF patients with different phenotypes: A retrospective registry-based study.
Koziar Vašáková M, Gregor J, Mogulkoc N, Kramer MR, Lewandowska K, Šterclová M, Müller V, Slivka R, Studnicka M, Plačková M, Žurková M, Tekavec-Trkanjec J, Doubková M, Ovesná P; EMPIRE investigators. Koziar Vašáková M, et al. Among authors: muller v. Respir Med. 2024 Nov-Dec;234:107791. doi: 10.1016/j.rmed.2024.107791. Epub 2024 Sep 8. Respir Med. 2024. PMID: 39255912
Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group. Saketkoo LA, et al. J Rheumatol. 2014 Apr;41(4):792-8. doi: 10.3899/jrheum.131251. Epub 2014 Feb 1. J Rheumatol. 2014. PMID: 24488412 Free PMC article. Review.
The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry.
Gregor J, Adir Y, Šterclová M, Mogulkoc N, Kramer MR, Doubková M, Plačková M, Müller V, Studnicka M, Žurková M, Lacina L, Lewandowska K, Bartoš V, Ovesná P, Májek O, Koziar Vašáková M. Gregor J, et al. Among authors: muller v. Arch Bronconeumol. 2024 Feb;60(2):80-87. doi: 10.1016/j.arbres.2023.12.002. Epub 2023 Dec 18. Arch Bronconeumol. 2024. PMID: 38160169 English, Spanish.
Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer.
Bartsch R, Cameron D, Ciruelos E, Criscitiello C, Curigliano G, Duhoux FP, Foukakis T, Gligorov J, Harbeck N, LeVasseur N, Okines A, Penault-Llorca F, Müller V. Bartsch R, et al. Among authors: muller v. Cancer Treat Rev. 2024 Nov 14;132:102853. doi: 10.1016/j.ctrv.2024.102853. Online ahead of print. Cancer Treat Rev. 2024. PMID: 39580869 Free article. Review.
Emergence of Escherichia coli ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024.
Kohlenberg A, Svartström O, Apfalter P, Hartl R, Bogaerts P, Huang TD, Chudejova K, Malisova L, Eisfeld J, Sandfort M, Hammerum AM, Roer L, Räisänen K, Dortet L, Bonnin RA, Tóth Á, Tóth K, Clarke C, Cormican M, Griškevičius A, Khonyongwa K, Meo M, Niedre-Otomere B, Vangravs R, Hendrickx AP, Notermans DW, Samuelsen Ø, Caniça M, Manageiro V, Müller V, Mäkitalo B, Kramar U, Pirs M, Palm D, Monnet DL, Alm E, Linkevicius M. Kohlenberg A, et al. Among authors: muller v. Euro Surveill. 2024 Nov;29(47):2400727. doi: 10.2807/1560-7917.ES.2024.29.47.2400727. Euro Surveill. 2024. PMID: 39574387 Free PMC article.
1,631 results